Korean J Crit Care Med.  2015 Nov;30(4):303-307. 10.4266/kjccm.2015.30.4.303.

Successful Application of Extracorporeal Membrane Oxygenation for a Patient with Clinical Amniotic Fluid Embolism

Affiliations
  • 1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
  • 2Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. cmcksc@gmail.com

Abstract

Amniotic fluid embolism (AFE) is a rare but potentially fatal complication that occurs acutely during pregnancy or within 12 h of delivery. The management of AFE focuses initially on supportive measures for cardiopulmonary stabilization. Extracorporeal membrane oxygenation should be considered in patients who are unresponsive to medical treatment in order to prevent additional hypoxia and subsequent organ failure. We present a 41-year-old woman with clinical AFE who developed acute respiratory distress syndrome and was treated successfully with extracorporeal membrane oxygenation.

Keyword

adult; amniotic fluid; embolism; extracorporeal membrane oxygenation; respiratory distress syndrome

MeSH Terms

Adult
Amniotic Fluid*
Anoxia
Embolism
Embolism, Amniotic Fluid*
Extracorporeal Membrane Oxygenation*
Female
Humans
Pregnancy
Respiratory Distress Syndrome, Adult

Figure

  • Fig. 1. Chest radiographs at (A) 3 h, (B) 12 h, and (C) 20 h after dilatation and curettage (D&C).

  • Fig. 2. Chest radiographs (A) on day 1 of extracorporeal membrane oxygenation (ECMO), (B) improved consolidations in both lungs on day 11 of ECMO, and (C) in the out-patient clinic seven days after discharge.

  • Fig. 3. Timeline of major clinical events. ECMO: extracorporeal membrane oxygenation; MV: mechanical ventilation.


Cited by  2 articles

Urgent Application of Extracorporeal Membrane Oxygenation in Amniotic Fluid Embolism
Moo Suk Park
Korean J Crit Care Med. 2016;31(3):179-180.    doi: 10.4266/kjccm.2016.00745.

Venous Air Embolism Not Amniotic Fluid Embolism
Charles Her
Korean J Crit Care Med. 2016;31(1):68-70.    doi: 10.4266/kjccm.2016.31.1.68.


Reference

References

1. Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res. 2014; 40:1507–17.
Article
2. Moore J, Baldisseri MR. Amniotic fluid embolism. Crit Care Med. 2005; 33(10 Suppl):S279–85.
Article
3. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995; 172(4 Pt 1):1158–67. discussion 1167-9.
Article
4. Clark SL. Amniotic fluid embolism. Obstet Gynecol. 2014; 123(2 Pt 1):337–48.
Article
5. Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009; 201:445. e1-13.
Article
6. Pantaleo G, Luigi N, Federica T, Paola S, Margherita N, Tahir M. Amniotic fluid embolism: review. Curr Pharm Biotechnol. 2014; 14:1163–7.
Article
7. de Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol. 2000; 182:760–6.
Article
8. Yoneyama K, Sekiguchi A, Matsushima T, Kawase R, Nakai A, Asakura H, et al. Clinical characteristics of amniotic fluid embolism: an experience of 29 years. J Obstet Gynaecol Res. 2014; 40:1862–70.
9. Ho CH, Chen KB, Liu SK, Liu YF, Cheng HC, Wu RS. Early application of extracorporeal membrane oxygenation in a patient with amniotic fluid embolism. Acta Anaesthesiol Taiwan. 2009; 47:99–102.
Article
10. Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol. 2000; 183:496–7.
Article
11. Ecker JL, Solt K, Fitzsimons MG, MacGillivray TE. Case records of the Massachusetts General Hospital. Case 40-2012. A 43-year-old woman with cardiorespiratory arrest after a cesarean section. N Engl J Med. 2012; 367:2528–36.
12. Reyftmann L, Morau E, Dechaud H, Frapier JM, Hedon B. Extracorporeal membrane oxygenation therapy for circulatory arrest due to postpartum hemorrhage. Obstet Gynecol. 2006; 107(2 Pt 2):511–4.
Article
13. Ito F, Akasaka J, Koike N, Uekuri C, Shigemitsu A, Kobayashi H. Incidence, diagnosis and pathophysiology of amniotic fluid embolism. J Obstet Gynaecol. 2014; 34:580–4.
Article
14. Uszyński M, Zekanowska E, Uszyński W, Kuczyński J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol. 2001; 95:163–6.
Article
15. Allen S, Holena D, McCunn M, Kohl B, Sarani B. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med. 2011; 26:13–26.
Article
16. Sharma NS, Wille KM, Bellot SC, Diaz-Guzman E. Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J. 2015; 61:110–4.
Article
Full Text Links
  • KJCCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr